Show simple item record

dc.contributor.authorFrancis, Ziad
dc.contributor.authorIncerti, Sebastien
dc.contributor.authorZein, Sara A
dc.contributor.authorLampe, Nathanael
dc.contributor.authorGuzman, Carlos A
dc.contributor.authorDurante, Marco
dc.date.accessioned2021-03-26T15:06:44Z
dc.date.available2021-03-26T15:06:44Z
dc.date.issued2021-01-07
dc.identifier.citationRadiat Res. 2021 Mar 1;195(3):221-229. doi: 10.1667/RADE-20-00241.1.en_US
dc.identifier.pmid33411888
dc.identifier.doi10.1667/RADE-20-00241.1
dc.identifier.urihttp://hdl.handle.net/10033/622800
dc.description.abstractImmunization with an inactivated virus is one of the strategies currently being tested towards developing a SARS-CoV-2 vaccine. One of the methods used to inactivate viruses is exposure to high doses of ionizing radiation to damage their nucleic acids. While gamma (γ) rays effectively induce lesions in the RNA, envelope proteins are also highly damaged in the process. This in turn may alter their antigenic properties, affecting their capacity to induce an adaptive immune response able to confer effective protection. Here, we modeled the effect of sparsely and densely ionizing radiation on SARS-CoV-2 using the Monte Carlo toolkit Geant4-DNA. With a realistic 3D target virus model, we calculated the expected number of lesions in the spike and membrane proteins, as well as in the viral RNA. Our findings showed that γ rays produced significant spike protein damage, but densely ionizing charged particles induced less membrane damage for the same level of RNA lesions, because a single ion traversal through the nuclear envelope was sufficient to inactivate the virus. We propose that accelerated charged particles produce inactivated viruses with little structural damage to envelope proteins, thereby representing a new and effective tool for developing vaccines against SARS-CoV-2 and other enveloped viruses.en_US
dc.language.isoenen_US
dc.publisherRadiation Research Societyen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleMonte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development.en_US
dc.typeArticleen_US
dc.identifier.eissn1938-5404
dc.contributor.departmentHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.en_US
dc.identifier.journalRadiation researchen_US
dc.source.volume195
dc.source.issue3
dc.source.beginpage221
dc.source.endpage229
refterms.dateFOA2021-03-26T15:06:45Z
dc.source.journaltitleRadiation research
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
Francis et al.pdf
Size:
4.282Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International